The REDEMPTION-3 eTrial is now open to patients with Genotypes 1 4 5 and 6.
REDEMPTION-3 is using tablets containing generic Harvoni ® (Sofosbuvir 400 mg / Ledipasvir 90 mg) sourced from a variety of reputable manufacturers such as Cipla, Incepta, Hetero, Natco, Beacon and Julphar.
There is no placebo, and the trial is open label (meaning you will know who made your medication), however you will not have a choice of manufacturer as part of the trial goal is to establish clinical equivalence between different manufacturers products and provision confidence in them.
You can download the Redemption-3 eTrail subscription form here. It describes the eTrial in detail.
You will also need to complete the online registration at Monkmed who are assisting us with both online medical consultations to handle the expected volume as well as the shipping of medications
GP2U Telehealth doctors are also available to provide consultations, prescriptions and monitoring for people unable to access their local doctor.
You will require a valid doctors prescription to participate.
The cost of entering the eTrial is $1600 USD for 12 weeks medication, or $3200 for 24 weeks supply (which will be shipped as 2 lots of 12 weeks to assist with importation into your country).